Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp CRRVF

Healthcare Biotechnology
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


GREY:CRRVF - Post by User

CVR Medical Corp
Bullboard Posts
User Avatar Image
(3)
•••
Comment by buyifisell1on Aug 07, 2019 3:37pm
71 Views
Post# 30003591

RE:RE:RE:Waiting Game

RE:RE:RE:Waiting Game
Lois,

Oldtimer and I have a different understanding of how the FDA procedes. Disagreeing is not, to my mind, "picking apart someone". I would hope we all are trying to get as clear a picture of what is happening as we can.  In the past, there was speculation that the FDA would approve or disapprove in something like 133 days. I went back to the FDA database and the average response took 298 days. Was I picking on the other posters by disagreeing?

BTW, where has it been confirmed that the FDA has requested more data? I don't recall seeing that.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities